BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25030801)

  • 1. The neurokinin-1 receptor antagonist aprepitant in co-morbid alcohol dependence and posttraumatic stress disorder: a human experimental study.
    Kwako LE; George DT; Schwandt ML; Spagnolo PA; Momenan R; Hommer DW; Diamond CA; Sinha R; Shaham Y; Heilig M
    Psychopharmacology (Berl); 2015 Jan; 232(1):295-304. PubMed ID: 25030801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NK1 receptor antagonism and the neural processing of emotional information in healthy volunteers.
    McCabe C; Cowen PJ; Harmer CJ
    Int J Neuropsychopharmacol; 2009 Oct; 12(9):1261-74. PubMed ID: 19545476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The corticotropin releasing hormone-1 (CRH1) receptor antagonist pexacerfont in alcohol dependence: a randomized controlled experimental medicine study.
    Kwako LE; Spagnolo PA; Schwandt ML; Thorsell A; George DT; Momenan R; Rio DE; Huestis M; Anizan S; Concheiro M; Sinha R; Heilig M
    Neuropsychopharmacology; 2015 Mar; 40(5):1053-63. PubMed ID: 25409596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods for inducing alcohol craving in individuals with co-morbid alcohol dependence and posttraumatic stress disorder: behavioral and physiological outcomes.
    Kwako LE; Schwandt ML; Sells JR; Ramchandani VA; Hommer DW; George DT; Sinha R; Heilig M
    Addict Biol; 2015 Jul; 20(4):733-46. PubMed ID: 24806358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcohol Abstainer Status and Prazosin Treatment in Association with Changes in Posttraumatic Stress Disorder Symptoms in Veterans with Comorbid Alcohol Use Disorder and Posttraumatic Stress Disorder.
    Verplaetse TL; Ralevski E; Roberts W; Gueorguieva R; McKee SA; Petrakis IL
    Alcohol Clin Exp Res; 2019 Apr; 43(4):741-746. PubMed ID: 30698839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NK1 receptor antagonists for depression: Why a validated concept was abandoned.
    Rupniak NMJ; Kramer MS
    J Affect Disord; 2017 Dec; 223():121-125. PubMed ID: 28753469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term NK1 receptor antagonism and emotional processing in healthy volunteers.
    Pringle A; McTavish SF; Williams C; Smith R; Cowen PJ; Harmer CJ
    Psychopharmacology (Berl); 2011 May; 215(2):239-46. PubMed ID: 21161182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid-like effects of the neurokinin 1 antagonist aprepitant in patients maintained on and briefly withdrawn from methadone.
    Jones JD; Speer T; Comer SD; Ross S; Rotrosen J; Reid MS
    Am J Drug Alcohol Abuse; 2013 Mar; 39(2):86-91. PubMed ID: 23421568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of NK1 receptors on gastric motor functions and satiation in healthy humans: results from a controlled trial with the NK1 antagonist aprepitant.
    Jacob D; Busciglio I; Burton D; Halawi H; Oduyebo I; Rhoten D; Ryks M; Harmsen WS; Camilleri M
    Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G505-G510. PubMed ID: 28814387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetylcysteine for the treatment of comorbid alcohol use disorder and posttraumatic stress disorder: Design and methodology of a randomized clinical trial.
    Back SE; Gray K; Santa Ana E; Jones JL; Jarnecke AM; Joseph JE; Prisciandaro J; Killeen T; Brown DG; Taimina L; Compean E; Malcolm R; Flanagan JC; Kalivas PW
    Contemp Clin Trials; 2020 Apr; 91():105961. PubMed ID: 32087337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot trial of prazosin, an alpha-1 adrenergic antagonist, for comorbid alcohol dependence and posttraumatic stress disorder.
    Simpson TL; Malte CA; Dietel B; Tell D; Pocock I; Lyons R; Varon D; Raskind M; Saxon AJ
    Alcohol Clin Exp Res; 2015 May; 39(5):808-17. PubMed ID: 25827659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NK1 receptor antagonism and emotional processing in healthy volunteers.
    Chandra P; Hafizi S; Massey-Chase RM; Goodwin GM; Cowen PJ; Harmer CJ
    J Psychopharmacol; 2010 Apr; 24(4):481-7. PubMed ID: 19351798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Oxytocin Administration on Cue-Induced Craving in Co-occurring Alcohol Use Disorder and PTSD: A Within-Participant Randomized Clinical Trial.
    Stauffer CS; Meinzer NK; Morrison T; Wen JH; Radanovich L; Leung D; Niles A; O'Donovan A; Batki SL; Woolley JD
    Alcohol Clin Exp Res; 2019 Dec; 43(12):2627-2636. PubMed ID: 31610033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prazosin for Veterans with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence: A Clinical Trial.
    Petrakis IL; Desai N; Gueorguieva R; Arias A; O'Brien E; Jane JS; Sevarino K; Southwick S; Ralevski E
    Alcohol Clin Exp Res; 2016 Jan; 40(1):178-86. PubMed ID: 26683790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placebo- and amitriptyline-controlled evaluation of central nervous system effects of the NK1 receptor antagonist aprepitant and intravenous alcohol infusion at pseudo-steady state.
    te Beek ET; Tatosian D; Majumdar A; Selverian D; Klaassen ES; Petty KJ; Gargano C; van Dyck K; McCrea J; Murphy G; van Gerven JM
    J Clin Pharmacol; 2013 Aug; 53(8):846-56. PubMed ID: 23775877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of efficacy of the substance p (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder.
    Keller M; Montgomery S; Ball W; Morrison M; Snavely D; Liu G; Hargreaves R; Hietala J; Lines C; Beebe K; Reines S
    Biol Psychiatry; 2006 Feb; 59(3):216-23. PubMed ID: 16248986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trauma- and Stress-Induced Response in Veterans with Alcohol Dependence and Comorbid Post-Traumatic Stress Disorder.
    Ralevski E; Southwick S; Jackson E; Jane JS; Russo M; Petrakis I
    Alcohol Clin Exp Res; 2016 Aug; 40(8):1752-60. PubMed ID: 27368085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of D-cycloserine on extinction of mesolimbic cue reactivity in alcoholism: a randomized placebo-controlled trial.
    Kiefer F; Kirsch M; Bach P; Hoffmann S; Reinhard I; Jorde A; von der Goltz C; Spanagel R; Mann K; Loeber S; Vollstädt-Klein S
    Psychopharmacology (Berl); 2015 Jul; 232(13):2353-62. PubMed ID: 25697860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence.
    Petrakis IL; Ralevski E; Desai N; Trevisan L; Gueorguieva R; Rounsaville B; Krystal JH
    Neuropsychopharmacology; 2012 Mar; 37(4):996-1004. PubMed ID: 22089316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional evaluation of NK
    Fonville L; Paterson L; Herlinger K; Hayes A; Hill R; Nutt D; Lingford-Hughes A
    Drug Alcohol Depend; 2021 Apr; 221():108564. PubMed ID: 33548897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.